|
Volume
18 Number 12
31 December 2016
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
18, Year 2016 >
Number 12, 31 December
|
|
|
|
|
|
Strebe
JK, Lubin JA, Kuo JS.
"Tag
Team" Glioblastoma Therapy: Results From a Phase 1 Trial of
Toca 511 and 5-Fluorocytosine for Recurrent High-Grade
Glioma.
Neurosurgery.
2016 Dec;79(6):N18-N20→.
doi: 10.1227/01.neu.0000508605.38694.fd→.
PMID: 27861411→.
Comment.
ˍ
Refers
to: Cloughesy
TF, et al., Phase 1 trial of vocimagene amiretrorepvec and
5-fluorocytosine for recurrent high-grade glioma.
Sci Transl
Med. 2016 Jun 1;8(341):341ra75→.
doi: 10.1126/scitranslmed.aad9784→.
PMID: 27252174→.
Interventional
study. ˍ
|
|
|
|
Cloughesy
T, Finocchiaro G, Belda-Iniesta C, Recht L, Brandes AA, Pineda E,
Mikkelsen T, Chinot OL, Balana C, Macdonald DR, Westphal M,
Hopkins K, Weller M, Bais C, Sandmann T, Bruey JM, Koeppen H, Liu
B, Verret W, Phan SC, Shames DS.
Randomized, Double-Blind,
Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus
Bevacizumab Versus Placebo Plus Bevacizumab
in Patients With Recurrent Glioblastoma: Efficacy, Safety, and
Hepatocyte Growth Factor and O6-Methylguanine-DNA
Methyltransferase Biomarker Analyses.
J
Clin Oncol.
2016 Dec 5, 2017;35(3):343-351→.
doi: 10.1200/JCO.2015.64.7685→.
PMID:
27918718→.
Interventional study.
ˍ
|
|
|
|
O'Connell
D, Shen V, Loudon W, Bota DA.
First
report of tumor treating fields use in combination with
bevacizumab in a pediatric patient: a Case report.
CNS
Oncol.
2016 Dec 5, 2017;6(1):11-18→.
doi: 10.2217/cns-2016-0018→.
PMID:
27918194→.
Case report. ˍ
|
|
|
|
Yoo
RE, Choi SH, Kim TM, Park CK, Park SH, Won JK, Kim IH, Lee ST,
Choi HJ, You SH, Kang KM, Yun TJ, Kim JH, Sohn CH.
Dynamic
contrast-enhanced MR imaging in predicting progression of
enhancing lesions persisting after standard treatment in
glioblastoma patients: a prospective study.
Eur
Radiol.
2016 Dec 14, 2017;27(8):3156-3166→.
doi: 10.1007/s00330-016-4692-9→.
PMID:
27975145→.
Interventional
study.
ˍ
|
|
|
|
Portnow
J, Synold TW, Badie B, Tirughana R, Lacey SF, D'Apuzzo M, Metz MZ,
Najbauer J, Bedell V, Vo T, Gutova M, Frankel P, Chen MY, Aboody
KS.
Neural
stem cell-based anti-cancer gene therapy: a first-in-human study
in recurrent high grade glioma patients.
Clin
Cancer Res.
2016 Dec 15, 2017;23(12):2951-2960→.
doi: 10.1158/1078-0432.CCR-16-1518→.
PMID:
27979915→.
Interventional
study.
ˍ
|
|
|
|
Winkler
F.
Tumour
network in glioma.
ESMO
Open.
2016 Dec 19, 2016;1(6):e000133→.
doi: 10.1136/esmoopen-2016-000133→.
PMID:
28255455→.
Podcast. ˍ
|
|
|
|
Esbenshade
AJ, Kocak M, Hershon L, Rousseau P, Decarie JC, Shaw S, Burger P,
Friedman HS, Gajjar A, Moghrabi A.
A
Phase II feasibility study of oral etoposide given concurrently
with radiotherapy followed by dose intensive adjuvant chemotherapy
for children with newly diagnosed high-risk medulloblastoma
(protocol POG 9631): A report from the Children's Oncology
Group.
Pediatr
Blood Cancer.
2016 Dec 21, 2017;64(6):10.1002/pbc.26373→.
doi: 10.1002/pbc.26373→.
PMID:
28000417→.
Interventional
study.
ˍ
|
|
|
|
Weller
M, Holland EC, Hambardzumyan D.
Reply:
Corticosteroids compromise survival in glioblastoma in part
through their elevation of blood glucose levels.
Brain.
2016 Dec 21, 2017;140(3):e17→.
doi: 10.1093/brain/aww325→.
PMID:
28007996→.
Comment. ˍ
Refers
to: Klement
RJ, et al.,
Corticosteroids
compromise survival in glioblastoma in part through their
elevation of blood glucose
levels.
Brain.
2016 Dec 30, 2017;140(3):e16→.
doi: 10.1093/brain/aww324→.
PMID:
28007995→.
Letter
to the Editor.
ˍ
In
turn referring to:
Pitter
KL, et al., Corticosteroids compromise survival in
glioblastoma.
Brain. 2016 Mar 28, 2016;139(Pt 5):1458-71→.
doi: 10.1093/brain/aww046→.
PMID: 27020328→.
Observational study. ˍ
|
|
|
|
Miller
C, Guillaume D, Dusenbery K, Clark HB, Moertel C.
Report
of effective trametinib therapy in 2 children with progressive
hypothalamic optic pathway pilocytic astrocytoma: documentation of
volumetric response.
J
Neurosurg Pediatr.
2016 Dec 23, 2017;19(3):319-324→.
doi: 10.3171/2016.9.PEDS16328→.
PMID: 28009226→.
Case report. ˍ
|
|
|
|
Peddi
P, Ajit NE, Burton GV, El-Osta H.
Regression
of a glioblastoma multiforme: spontaneous versus a potential
antineoplastic effect of dexamethasone and levetiracetam.
BMJ
Case Rep.
2016 Dec 23, 2016:bcr2016217393→.
doi: 10.1136/bcr-2016-217393→.
PMID:
28011886→.
Case report. ˍ
|
|
|
|
Toledo
M, Sarria-Estrada S, Quintana M, Maldonado X, Martinez-Ricarte F,
Rodon J, Auger C, Aizpurua M, Salas-Puig J, Santamarina E,
Martinez-Saez E.
Epileptic
features and survival in glioblastomas presenting with
seizures.
Epilepsy
Res.
2016 Dec 26,
2017;130:1-6→.
doi: 10.1016/j.eplepsyres.2016.12.013→.
PMID: 28073027→.
Interventional
study.
ˍ
|
|
|
|
Zwirner
K, Paulsen F, Schittenhelm J, Borchers C, Skardelly M, Zips D,
Eckert F.
Prognostic
parameters and outcome after re-irradiation for progressive
glioblastoma.
Acta
Neurol Scand.
2016 Dec 26, 2017;136(3):239-245→.
doi: 10.1111/ane.12719→.
PMID: 28025828→.
Observational
study. ˍ
|
|
|
|
Brown
CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, Ostberg JR,
Blanchard MS, Kilpatrick J, Simpson J, Kurien A, Priceman SJ, Wang
X, Harshbarger TL, D'Apuzzo M, Ressler JA, Jensen MC, Barish ME,
Chen M, Portnow J, Forman SJ, Badie B.
Regression
of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
N
Engl J Med.
2016 Dec 29, 2016;375(26):2561-9→.
doi: 10.1056/NEJMoa1610497→.
PMID:
28029927→.
Interventional
study.
ˍ
|
|
|
|
Reardon
DA, Lassman AB, van den Bent M, Kumthekar P, Merrell R, Scott AM,
Fichtel L, Sulman EP, Gomez E, Fischer J, Lee HJ, Munasinghe W,
Xiong H, Mandich H, Roberts-Rapp L, Ansell P, Holen KD, Gan HK.
Efficacy
and safety results of ABT-414 in combination with radiation and
temozolomide in newly diagnosed glioblastoma.
Neuro
Oncol.
2016 Dec 29, 2017;19(7):965-975→.
doi: 10.1093/neuonc/now257→.
PMID: 28039367→.
Interventional
study.
ˍ
|
|
|
|
Becher
OJ, Gilheeney SW, Khakoo Y, Lyden DC, Haque S, De Braganca KC,
Kolesar JM, Huse JT, Modak S, Wexler LH, Kramer K, Spasojevic I,
Dunkel IJ.
A
phase I study of perifosine with temsirolimus for recurrent
pediatric solid tumors.
Pediatr
Blood Cancer.
2016 Dec 30. 2017;64(7):e26409→.
doi: 10.1002/pbc.26409→.
PMID:
28035748→.
Interventional
study.
ˍ
|
|
|
|
Klement
RJ, Champ CE.
Corticosteroids
compromise survival in glioblastoma in part through their
elevation of blood glucose levels.
Brain.
2016 Dec 30, 2017;140(3):e16→.
doi: 10.1093/brain/aww324→.
PMID:
28007995→.
Letter
to the Editor.
ˍ
Refers
to: Pitter
KL, et al., Corticosteroids compromise survival in
glioblastoma.
Brain. 2016 Mar 28, 2016;139(5):1458-71→.
doi: 10.1093/brain/aww046→.
PMID:
27020328→.
Observational
study.
ˍ
|
|
|
|
|
|
|
|
|
